Molecular ion mass identification confirmed 1418 Da for BPC-157 and 4963 Da for TB-500
Diabetes Care 31 , 464469 (2008)
Dizziness may occur, particularly if rapid weight loss leads to postural hypotension or if patients are concurrently taking antihypertensive medications that require dose adjustment
Study records: PCO-02 safety and pharmacokinetics trial, Pentadecapeptide BPC 157 for Acute Grade II Hamstring Strain (NCT07437547), Intra-articular injection of BPC 157 for multiple types of knee pain, Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study, Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review, A new gastric juice peptide, BPC, and characterization of its 15 amino acid fragment BPC 157, BPC-157 protection against gastric and duodenal lesions in rat ulcer models Evidence boundary: These records do not test the vial, capsule, nasal-spray, and topical formats observed in the research-use market, and the preclinical findings do not establish human efficacy for any indication
2021;4(2):e2035693